Ansa Biotechnologies Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $4.73M
Latest Deal Amount
  • Investors
  • 2

Ansa Biotechnologies General Information

Description

Developer of a novel DNA synthesis technology intended to simplify the biological research process. The company's technology accelerates innovation in biological research and engineering based on polymerase-nucleotide conjugates that have the ability to extend a DNA molecule, thereby allowing the healthcare industry to fasten defined nucleotide additions research by TdT while unlocking the potential of enzymatic de novo DNA synthesis.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Bonneville Labs, 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States

Ansa Biotechnologies Timeline

20192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ansa Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 09-Jul-2020 $4.73M Completed Startup
2. Early Stage VC 01-Jan-2020 Completed Startup
1. Grant 19-Jun-2019 $225K Completed Startup
To view Ansa Biotechnologies’s complete valuation and funding history, request access »

Ansa Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a novel DNA synthesis technology intended to simplify the biological research process. The company's techno
Biotechnology
Berkeley, CA
5 As of 2020
000000000

00000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000000000000
San Diego, CA
00 As of 0000
000.00
0000000000 0 000.00

000 0000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
0000000000000
France
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ansa Biotechnologies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Molecular Assemblies Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
000 000000 Venture Capital-Backed France 00000 00000000000 00000
00000 0000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
0000000000 000 000 Formerly PE-Backed Skokie, IL 0000 00000 000000&0 00000
You’re viewing 5 of 7 competitors. Get the full list »

Ansa Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Daniel Lin-Arlow Ph.D Chief Executive Officer & Board Member
Sebastian Palluk Chief Technology Officer & Board Member
To view Ansa Biotechnologies’s complete executive team members history, request access »

Ansa Biotechnologies Board Members (2)

Name Representing Role Since
Daniel Lin-Arlow Ph.D Ansa Biotechnologies Chief Executive Officer & Board Member 000 0000
Sebastian Palluk Ansa Biotechnologies Chief Technology Officer & Board Member 000 0000
To view Ansa Biotechnologies’s complete board members history, request access »

Ansa Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ansa Biotechnologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fifty Years Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Ansa Biotechnologies’s complete investors history, request access »